Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its impl
| Image |  |
|---|---|
| Description | scientific article published in December 2007 |
| Author/s |
author: American Society of Clinical Oncology College of American Pathologists |
| Publication date | December 1, 2007 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |